Search Results
Viewing: 6571-6580 of 11689 | All
Article
Familles et patients internationaux
Lorsque votre enfant a besoin d’un hôpital, tout est important. Bienvenue à Nationwide Children’s Hospital, où nous créons le futur des soins de santé pédiatriques. Reconnus aux niveaux national et international, nos médecins et chercheurs transforment les soins de nos enfants et des enfants des générations futures.
Article
Pazienti e famiglie internazionali
Quando il vostro bambino ha bisogno di un ospedale, tutto è importante. Benvenuti al Nationwide Children’s Hospital, dove stiamo plasmando il futuro della sanità pediatrica.
Article
Pacientes y familias de otros paises
Cuando su hijo necesita ser atendido en un hospital, todo es importante. Bienvenido al Nationwide Children’s. Aquí estamos creando el futuro de la atención médica infantil.
Specialty
For Domestic Patients
Nationwide Children’s Hospital Global Patient Services assists out-of-area and international families with concierge services such as travel arrangements, lodging and connections to needed resources to make your family’s visit to Columbus as comfortable as possible.
Blog
5 Questions Every NICU Parent Should Ask
Having a baby in the Neonatal Intensive Care Unit (NICU) can be overwhelming and it can take a while to adjust. Here are 5 questions you might find helpful to ask as a NICU parent.
Blog
Fewer Ouchies and More Fun – 5 Tips for Playground Safety
More than 213,000 kids younger than 18 years are treated in US hospital emergency departments for playground-related injuries every year. Here are a few tips to help make the playground adventure safer.
About the MDSRC
Researchers in the Jerry R. Mendell, MD Center for Gene Therapy at Nationwide Children's Hospital have received a coveted P50 grant from the National Institutes of Health to establish a Wellstone Muscular Dystrophy Specialized Research Center (MDSRC). Named in honor of the late Senator Paul D.
Project 1
Led by Paul Marin, PhD, Research Project 1 of our MDSRC Program is dedicated to completing remaining pre-clinical proof of concept and safety studies required to file a pre-IND application with the FDA for a first-in-class bicistronic AAV gene therapy for patients with Limb Girdle Muscular Dystrophy Type R9 (LGMDR9).
Project 2
Led by Kevin Flanigan, MD, Research Project 2 of our MDSRC Program has a long-term goal to develop vectors that maximize RNA splice alteration efficiency to provide the best potential outcome for individual patients.